                               SEQUENCE LISTING	

<110> NOVADRUG, LLC
 
<120> COMPOSITIONS AND METHODS FOR TREATING VIRAL DISEASES

<130> 45988-114123

<140>
<141>

<150> 61/309,328
<151> 2010-03-01

<160> 8     

<170> PatentIn version 3.5

<210> 1
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 1
aggtttagga ttcgtgctca t                                                 21


<210> 2
<211> 27
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      probe


<220>
<223> 5'-6-FAM

<220>
<223> 3'-TAMRA

<400> 2
caccctatca ggcagtacca caaggcc                                           27


<210> 3
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 3
tgcggaaccg gtgagtaca                                                    19


<210> 4
<211> 21
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 4
aggtttagga ttcgtgctca t                                                 21


<210> 5
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 5
gaaggtgaag gtcggagtc                                                    19


<210> 6
<211> 20
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 6
gaagatggtg atgggatttc                                                   20


<210> 7
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 7
tctgcggaac cggtgagta                                                    19


<210> 8
<211> 19
<212> DNA
<213> Artificial Sequence

<220>
<223> Description of Artificial Sequence: Synthetic
      primer

<400> 8
tcaggcagta ccacaaggc                                                    19


